{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:33:28Z","timestamp":1791329608290,"version":"4.3.1"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ISF College of Pharmacy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejmech.2020.112438","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:11:56Z","timestamp":1589580716000},"page":"112438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"special_numbering":"C","title":["Recent advancements in the development of heterocyclic anti-inflammatory agents"],"prefix":"10.1016","volume":"200","author":[{"given":"Sahil","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112438_bib1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112438_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-1759(02)00414-3","article-title":"Chemokine receptors in inflammation: an overview","volume":"273","author":"D\u2019Ambrosio","year":"2003","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2020.112438_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: new adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112438_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112438_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archinte.1931.00150020080005","article-title":"Inflammation: a protective mechanism","volume":"48","author":"Menkin","year":"1931","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejmech.2020.112438_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2020.112438_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1530\/REP-09-0247","article-title":"Inflammatory pathways in female reproductive health and disease","volume":"138","author":"Jabbour","year":"2009","journal-title":"Reproduction"},{"key":"10.1016\/j.ejmech.2020.112438_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112438_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-065X.2000.17702.x","article-title":"Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses","volume":"177","author":"Chertov","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejmech.2020.112438_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1159\/000452591","article-title":"Triptolide attenuates inflammatory response in membranous glomerulo-nephritis rat via downregulation of NF-\u03baB signaling pathway","volume":"41","author":"Zhou","year":"2016","journal-title":"Kidney Blood Pres. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ejmech.2020.112438_bib12","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2020.112438_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2020.112438_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/09680519050110060301","article-title":"How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals","volume":"11","author":"Fritz","year":"2005","journal-title":"J.\u00a0Endotoxin Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib15","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2015"},{"key":"10.1016\/j.ejmech.2020.112438_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.14202\/vetworld.2018.627-635","article-title":"The crucial roles of inflammatory mediators in inflammation: a review","volume":"11","author":"Abdulkhaleq","year":"2018","journal-title":"Vet. World"},{"key":"10.1016\/j.ejmech.2020.112438_bib17","doi-asserted-by":"crossref","first-page":"9524075","DOI":"10.1155\/2018\/9524075","article-title":"Role of histamine in modulating the immune response and inflammation","volume":"2018","author":"Branco","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2020.112438_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnpit.2017.00400","article-title":"The role of serotonin beyond the central nervous system during embryogenesis","volume":"11","author":"Lv","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112438_bib19","series-title":"Mediators of Inflammation","author":"Weissmann","year":"2013"},{"key":"10.1016\/j.ejmech.2020.112438_bib20","first-page":"147","article-title":"Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat","volume":"114","author":"Baumann","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejmech.2020.112438_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.anai.2014.06.005","article-title":"Primer to the immune response","volume":"113","author":"Hsieh","year":"2014","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejmech.2020.112438_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1113\/jphysiol.2004.071159","article-title":"Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium","volume":"562","author":"Chopra","year":"2005","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.ejmech.2020.112438_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fendo.2017.00082","article-title":"Involvement of the bradykinin B1 receptor in microglial activation: in\u00a0vitro and in\u00a0vivo studies","volume":"8","author":"Asraf","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2020.112438_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2020.112438_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.archger.2003.10.001","article-title":"Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)\/cycloxigenase (COX) inhibition concept","volume":"38","author":"Gaddi","year":"2004","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.ejmech.2020.112438_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"R\u00e5dmark","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejmech.2020.112438_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.otc.2010.04.003","article-title":"A\u00a0comprehensive review of the adverse effects of systemic corticosteroids","volume":"43","author":"Poetker","year":"2010","journal-title":"Otolaryngol. Clin."},{"key":"10.1016\/j.ejmech.2020.112438_bib29","first-page":"f3195","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"346","author":"Day","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2020.112438_bib30","first-page":"821","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2020.112438_bib31","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/ph3051530","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs): progress in small molecule drug development","volume":"3","author":"Rao","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2020.112438_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0959-440X(01)00277-9","article-title":"Cyclooxygenase enzymes: catalysis and inhibition","volume":"11","author":"Kurumbail","year":"2001","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2020.112438_bib33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/0929867024606650","article-title":"Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks","volume":"9","author":"Bertolini","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib34","first-page":"17","article-title":"Role of inducible cyclooxygenase (COX-2) in inflammation","volume":"4","author":"Seibert","year":"1994","journal-title":"Receptor"},{"key":"10.1016\/j.ejmech.2020.112438_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd1034","article-title":"The development of COX2 inhibitors","volume":"2","author":"Flower","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112438_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200363010-00003","article-title":"The second generation of COX-2 inhibitors","volume":"63","author":"Stichtenoth","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112438_bib37","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2020.112438_bib38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/0929867003374219","article-title":"Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract","volume":"7","author":"Kirchrath","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib39","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2174\/138161207781368774","article-title":"Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks","volume":"13","author":"Martinez-Gonzalez","year":"2007","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2020.112438_bib40","first-page":"81","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2020.112438_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bioorg.2018.05.014","article-title":"Benzimidazole scaffold based hybrid molecules for various inflammatory targets: synthesis and evaluation","volume":"80","author":"Kaur","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib42","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1096\/fj.11-181958","article-title":"Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson\u2019s disease models","volume":"25","author":"Domanskyi","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2020.112438_bib43","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib44","doi-asserted-by":"crossref","first-page":"103291","DOI":"10.1016\/j.bioorg.2019.103291","article-title":"Recent advances in the synthetic and medicinal perspective of quinolones: a review","volume":"92","author":"Dhiman","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1568009616666160928110818","article-title":"Mechanisms of tubulin binding ligands to target cancer cells: updates on their therapeutic potential and clinical trials","volume":"17","author":"Kumar","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2020.112438_bib46","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1389557511313060012","article-title":"A\u00a0biological review","volume":"13","author":"Marella","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/157489109789318569","article-title":"Biological activities of pyrazoline derivatives-A recent development","volume":"4","author":"Kumar","year":"2009","journal-title":"Recent Pat. Anti-Infect. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112438_bib48","doi-asserted-by":"crossref","first-page":"1900029","DOI":"10.1002\/ardp.201900029","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors","volume":"352","author":"Chauhan","year":"2019","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2020.112438_bib49","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.ejmech.2010.01.029","article-title":"In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives","volume":"45","author":"Achar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1517\/13543776.2015.1015987","article-title":"New substituted benzimidazole derivatives: a patent review (2013\u20132014)","volume":"25","author":"Wang","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2020.112438_bib51","first-page":"287","article-title":"Indole as a core anti-inflammatory agent-a mini review","volume":"2","author":"Hemalatha","year":"2013","journal-title":"Chem. Sci. Rev. Lett."},{"key":"10.1016\/j.ejmech.2020.112438_bib52","series-title":"Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-activity Relationship Studies, Current Drug Targets Accepted","author":"Kumar","year":"2020"},{"key":"10.1016\/j.ejmech.2020.112438_bib53","first-page":"171","article-title":"Pharmacological potentials of pyrimidine derivative: a review","volume":"8","author":"Dansena","year":"2015","journal-title":"Asian J. Pharmaceut. Clin. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib54","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2174\/13895575113139990078","article-title":"Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents","volume":"13","author":"Liu","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib55","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2174\/1389557511009011014","article-title":"Pyrazoles as promising scaffold for the synthesis of anti-inflammatory and\/or antimicrobial agent: a review","volume":"10","author":"Bekhit","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib56","first-page":"51","article-title":"Recent review on indole: a privileged scaffold structure","volume":"7","author":"Naim","year":"2016","journal-title":"Int. J. Pharmaceut. Sci. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","article-title":"Indole in the target-based design of anticancer agents: a versatile scaffold with diverse mechanisms","volume":"150","author":"Dadashpour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib58","first-page":"9","article-title":"Recent progress in biological activities of indole and indole alkaloids","volume":"18","author":"Singh","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib59","first-page":"921","article-title":"Tryptophan biosynthesis and metabolism: biochemical and molecular genetics","volume":"7","author":"Radwanski","year":"1995","journal-title":"Plant Cell"},{"key":"10.1016\/j.ejmech.2020.112438_bib60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejmech.2019.07.019","article-title":"An insight into the medicinal perspective of synthetic analogs of indole: a review","volume":"180","author":"Thanikachalam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2020.112438_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jep.2015.01.042","article-title":"Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson\u05f3 s disease","volume":"164","author":"Wang","year":"2015","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2020.112438_bib63","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/ph7121028","article-title":"Role of microglial m1\/m2 polarization in relapse and remission of psychiatric disorders and diseases","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2020.112438_bib64","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbadis.2016.05.024","article-title":"Modulation of microglia polarization dynamics during diabetic retinopathy in db\/db mice","volume":"1862","author":"Arroba","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2020.112438_bib65","doi-asserted-by":"crossref","first-page":"103023","DOI":"10.1016\/j.bioorg.2019.103023","article-title":"Design, synthesis, modeling studies and biological screening of novel pyrazole derivatives as potential analgesic and anti-inflammatory agents","volume":"89","author":"Taher","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib66","doi-asserted-by":"crossref","first-page":"103110","DOI":"10.1016\/j.bioorg.2019.103110","article-title":"An efficient method for the synthesis of novel derivatives 4-{5-[4-(4-amino-5-mercapto-4H-[1, 2, 4] triazol-3-yl)-phenyl]-3-trifluoromethyl-pyrazol-1-yl}-benzenesulfonamide and their anti-inflammatory potential","volume":"91","author":"Mustafa","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib67","first-page":"1","article-title":"Synthesis and anti-inflammatory evaluation of some new pyrazole, pyrimidine, pyrazolo [1, 5-a] pyrimidine, imidazo [1, 2-b] pyrazole and pyrazolo [5, 1-b] quinazoline derivatives containing indane moiety","author":"El-Sayed","year":"2019","journal-title":"Polycycl. Aromat. Comp."},{"key":"10.1016\/j.ejmech.2020.112438_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bioorg.2019.03.071","article-title":"Unveiling novel diphenyl-1H-pyrazole based acrylates tethered to 1, 2, 3-triazole as promising apoptosis inducing cytotoxic and anti-inflammatory agents","volume":"87","author":"Khan","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejmech.2019.03.052","article-title":"New pyrazole derivatives: synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES","volume":"171","author":"Hassan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib70","doi-asserted-by":"crossref","first-page":"103220","DOI":"10.1016\/j.bioorg.2019.103220","article-title":"Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents","volume":"92","author":"Gulnaz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib71","doi-asserted-by":"crossref","first-page":"103132","DOI":"10.1016\/j.bioorg.2019.103132","article-title":"Thiohydantoin derivatives incorporating a pyrazole core: design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities","volume":"91","author":"Abdellatif","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bioorg.2018.10.014","article-title":"Synthesis of new pyrazoles and pyrozolo [3, 4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme","volume":"83","author":"Mohamed","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2019.02.095","article-title":"Synthesis, molecular structure and multiple biological activities of N-(3-methoxyphenyl)-3-(pyridin-4-yl)-1H-pyrazole-5-carboxamide","volume":"1186","author":"Nithyabalaji","year":"2019","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2020.112438_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bioorg.2019.02.031","article-title":"Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors","volume":"86","author":"Murahari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2019.03.042","article-title":"Novel benzenesulfonamide and 1, 2-benzisothiazol-3 (2H)-one-1, 1-dioxide derivatives as potential selective COX-2 inhibitors","volume":"171","author":"Taher","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib76","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jhet.3118","article-title":"Anti-inflammatory exploration of sulfonamide containing diaryl pyrazoles with promising COX-2 selectivity and enhanced gastric safety profile","volume":"55","author":"Pavase","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib77","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bioorg.2018.02.018","article-title":"Non-acidic 1, 3, 4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"77","author":"Abdellatif","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib78","doi-asserted-by":"crossref","first-page":"172435","DOI":"10.1098\/rsos.172435","article-title":"Microwave-assisted synthesis, computational studies and antibacterial\/anti-inflammatory activities of compounds based on coumarin-pyrazole hybrid","volume":"5","author":"Chavan","year":"2018","journal-title":"Roy. Soc. Open Sci."},{"key":"10.1016\/j.ejmech.2020.112438_bib79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10787-017-0390-8","article-title":"Anti-inflammatory effect of a new piperazine derivative:(4-methylpiperazin-1-yl)(1-phenyl-1H-pyrazol-4-yl) methanone","volume":"26","author":"Batista","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejmech.2020.112438_bib80","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1007\/s00044-017-2000-0","article-title":"Analgesic, anti-inflammatory, and antimicrobial activities of novel isoxazole\/pyrimidine\/pyrazole substituted benzimidazole analogs","volume":"26","author":"Chikkula","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib81","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bioorg.2017.08.014","article-title":"Pyrazole-hydrazone derivatives as anti-inflammatory agents: design, synthesis, biological evaluation, COX-1, 2\/5-LOX inhibition and docking study","volume":"74","author":"Abdelgawad","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib82","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00044-016-1744-2","article-title":"Synthesis of novel \u03b1, \u03b1-difluoro-\u03b2-hydroxycarbonyl pyrazole derivatives as antioxidant, anti-inflammatory and anticancer agents","volume":"26","author":"Mukarram","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib83","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jhet.2722","article-title":"Synthesis, antioxidant, and anti-inflammatory evaluation of novel thiophene-fused quinoline based \u03b2-diketones and derivatives","volume":"54","author":"Mahajan","year":"2017","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2016.09.021","article-title":"Synthesis, characterization and molecular docking studies of substituted 4-coumarinylpyrano [2, 3-c] pyrazole derivatives as potent antibacterial and anti-inflammatory agents","volume":"125","author":"Chougala","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bioorg.2019.01.031","article-title":"COX-1\/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core","volume":"86","author":"Abdelall","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib86","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/molecules22111960","article-title":"Design, synthesis, and biological activity of tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidine derivatives as anti-inflammatory agents","volume":"22","author":"Zhang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112438_bib87","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bioorg.2019.03.037","article-title":"Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38\u03b1 MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-\u03b1 inhibitory properties","volume":"87","author":"Somakala","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib88","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bioorg.2019.02.014","article-title":"Anti-inflammatory drug approach: synthesis and biological evaluation of novel pyrazolo [3, 4-d] pyrimidine compounds","volume":"86","author":"Atatreh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib89","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/14756366.2019.1618291","article-title":"Design and synthesis of novel pyrazolo [4, 3-d] pyrimidines as potential therapeutic agents for acute lung injury","volume":"34","author":"Wang","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib90","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bioorg.2018.03.030","article-title":"Design, synthesis and evaluation of some pyrazolo [3, 4-d] pyrimidines as anti-inflammatory agents","volume":"78","author":"Tageldin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bioorg.2018.06.013","article-title":"Design, synthesis and evaluation of some pyrazolo [3, 4-d] pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents","volume":"80","author":"Tageldin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib92","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s11164-017-3155-5","article-title":"A\u00a0simple and efficient one-pot novel synthesis of pyrazolo [3, 4-b][1, 8] naphthyridine and pyrazolo [3, 4-d] pyrimido [1, 2-a] pyrimidine derivatives as anti-inflammatory agents","volume":"44","author":"Patil","year":"2018","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2020.112438_bib93","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/14756366.2015.1022174","article-title":"3-Methyl-2-phenyl-1-substituted-indole derivatives as indomethacin analogs: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents","volume":"31","author":"Abdellatif","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib94","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/cbdd.12581","article-title":"Synthesis and anti-neuroinflammatory activity of lactone benzoyl hydrazine and 2-nitro-1-phenyl-1H-indole derivatives as p38\u03b1 MAPK inhibitors","volume":"86","author":"Cheng","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112438_bib95","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.3390\/ijms16036532","article-title":"Discovery of benzo [f] indole-4, 9-dione derivatives as new types of anti-inflammatory agents","volume":"16","author":"Chen","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2020.112438_bib96","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ejmech.2016.08.013","article-title":"Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: synthesis, biological activities in\u00a0vitro and docking study","volume":"123","author":"Lamie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib97","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1021\/acs.jmedchem.5b02006","article-title":"Design, synthesis, and structure\u2013activity relationship study of novel indole-2-carboxamide derivatives as anti-inflammatory agents for the treatment of sepsis","volume":"59","author":"Liu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib98","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3109\/14756366.2016.1151015","article-title":"Synthesis and anti-inflammatory activity evaluation of novel triazolyl-isatin hybrids","volume":"31","author":"Sharma","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib99","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bmcl.2017.02.052","article-title":"Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents","volume":"27","author":"Bhale","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112438_bib100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2017.09.003","article-title":"TNF-\u03b1 and IL-6 inhibitors: conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents","volume":"140","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib101","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/molecules23061250","article-title":"Indole derivatives as cyclooxygenase inhibitors: synthesis, biological evaluation and docking studies","volume":"23","author":"Bhat","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112438_bib102","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.4155\/fmc-2018-0224","article-title":"Anti-inflammatory indomethacin analogs endowed with preferential COX-2 inhibitory activity","volume":"10","author":"Amin","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib103","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejmech.2018.10.014","article-title":"Design, synthesis and biological evaluation of novel 2-sulfonylindoles as potential anti-inflammatory therapeutic agents for treatment of acute lung injury","volume":"160","author":"Xia","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib104","article-title":"Design, synthesis, and biological evaluation of 2-(4-(methylsulfonyl) phenyl) indole derivatives with promising COX-2 inhibitory activity","volume":"8","author":"Shaker","year":"2018","journal-title":"J.\u00a0Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2020.112438_bib105","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1016\/j.bmc.2018.07.024","article-title":"Synthesis, in\u00a0vitro and in\u00a0vivo biological evaluation, COX-1\/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives","volume":"26","author":"Moraes","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2019.07.004","article-title":"Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX","volume":"180","author":"Huang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejmech.2019.03.022","article-title":"Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury","volume":"171","author":"Song","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2018.10.013","article-title":"Bioactive monoterpene indole alkaloids from Nauclea officinalis","volume":"83","author":"Liu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib109","series-title":"Design, synthesis and pharmacological evaluation of gastro-protective anti-inflammatory analgesic agents based on dual oxidative stress\/cyclooxygenase inhibition, anti-inflammatory & anti-allergy agents in medicinal chemistry","author":"Gaba","year":"2019"},{"key":"10.1016\/j.ejmech.2020.112438_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bioorg.2018.10.048","article-title":"New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: synthesis, in-vitro and in-vivo screening and molecular modeling studies","volume":"83","author":"El-Kerdawy","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib111","doi-asserted-by":"crossref","first-page":"103218","DOI":"10.1016\/j.bioorg.2019.103218","article-title":"New pyrimidine-benzoxazole\/benzimidazole hybrids: synthesis, antioxidant, cytotoxic activity, in\u00a0vitro cyclooxygenase and phospholipase A2-V inhibition","volume":"92","author":"Abdelgawad","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/hc-2019-0009","article-title":"Synthesis and biological evaluation of (E)-N\u2019-Benzylidene-7-methyl-2-propyl-1H-benzo [d] imidazole-5-carbohydrazides as antioxidant, anti-inflammatory and analgesic agents","volume":"25","author":"Katikireddy","year":"2019","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.ejmech.2020.112438_bib113","doi-asserted-by":"crossref","first-page":"1800265","DOI":"10.1002\/ardp.201800265","article-title":"Design, synthesis, and biological evaluation of new pyrazino [1, 2-a] benzimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors","volume":"352","author":"Azami Movahed","year":"2019","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2020.112438_bib114","doi-asserted-by":"crossref","first-page":"1800030","DOI":"10.1002\/ardp.201800030","article-title":"Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity","volume":"351","author":"Nandha","year":"2018","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2020.112438_bib115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/1871523017666180426125141","article-title":"Characterization and molecular docking studies of novel N-(benzimidazol-1-ylmethyl)-4-chlorobenzamide analogues for potential anti-inflammatory and antimicrobial activity","volume":"17","author":"Sethi","year":"2018","journal-title":"Anti-Inflammatory Anti-Allergy Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib116","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bioorg.2017.07.007","article-title":"Design, synthesis and biological evaluation of some novel benzothiazole\/benzoxazole and\/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents","volume":"74","author":"Abdelgawad","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib117","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00044-017-1897-7","article-title":"Synthesis and biological evaluation of new 2-(6-alkyl-pyrazin-2-yl)-1H-benz [d] imidazoles as potent anti-inflammatory and antioxidant agents","volume":"26","author":"Shankar","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112438_bib118","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/molecules22020213","article-title":"Synthesis and biological evaluation of novel benzimidazole derivatives and analogs targeting the NLRP3 inflammasome","volume":"22","author":"Pan","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112438_bib119","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.bmcl.2017.05.017","article-title":"Synthesis of methanesulphonamido-benzimidazole derivatives as gastro-sparing antiinflammatory agents with antioxidant effect","volume":"27","author":"Sharma","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112438_bib120","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4155\/fmc-2016-0062","article-title":"Anti-inflammatory trends of new benzimidazole derivatives","volume":"8","author":"Bukhari","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib121","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bioorg.2016.11.014","article-title":"In\u00a0vivo anti-inflammatory activity and docking study of newly synthesized benzimidazole derivatives bearing oxadiazole and morpholine rings","volume":"70","author":"Rathore","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib122","doi-asserted-by":"crossref","first-page":"19475","DOI":"10.1039\/C5RA25071D","article-title":"In\u00a0vivo assessment of newly synthesized achiral copper (II) and zinc (II) complexes of a benzimidazole derived scaffold as a potential analgesic, antipyretic and anti-inflammatory","volume":"6","author":"AlAjmi","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112438_bib123","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1039\/C8MD00457A","article-title":"Rationally synthesized coumarin based pyrazolines ameliorate carrageenan induced inflammation through COX-2\/pro-inflammatory cytokine inhibition","volume":"10","author":"Chandel","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2020.112438_bib124","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.steroids.2019.03.012","article-title":"Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents","volume":"146","author":"Cai","year":"2019","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2020.112438_bib125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4155\/fmc-2016-0242","article-title":"Synthesis, evaluation and modeling of some triazolothienopyrimidinones as anti-inflammatory and antimicrobial agents","volume":"9","author":"Bekhit","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib126","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/molecules24061162","article-title":"Discovery of 2-substituted 3-arylquinoline derivatives as potential anti-inflammatory agents through inhibition of LPS-induced inflammatory responses in macrophages","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112438_bib127","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/molecules25010220","article-title":"Synthesis of novel benzodifuranyl; 1, 3, 5-triazines; 1, 3, 5-oxadiazepines; and thiazolopyrimidines derived from visnaginone and khellinone as anti-inflammatory and analgesic agents","volume":"25","author":"Abu-Hashem","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112438_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900233","article-title":"1, 2, 4-Triazole-conjugated 1, 3, 4-thiadiazole hybrid scaffolds: a potent ameliorant of carrageenan-induced inflammation by lessening proinflammatory mediators","author":"Pathak","year":"2020","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2020.112438_bib129","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/ange.201912489","article-title":"Synthesis and target identification of benzoxepane derivatives as potential anti-neuroinflammatory agents for ischemic stroke","volume":"132","author":"Gao","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib130","doi-asserted-by":"crossref","first-page":"12452","DOI":"10.1021\/acs.joc.9b01754","article-title":"Synthesis of isoxazolines by the electrophilic chalcogenation of \u03b2, \u03b3-unsaturated oximes: fishing novel anti-inflammatory agents","volume":"84","author":"Lopes","year":"2019","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib131","doi-asserted-by":"crossref","first-page":"115053","DOI":"10.1016\/j.bmc.2019.115053","article-title":"Synthesis and highly potent anti-inflammatory activity of licofelone-and ketorolac-based 1-arylpyrrolizin-3-ones","volume":"27","author":"Madrigal","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib132","doi-asserted-by":"crossref","first-page":"111604","DOI":"10.1016\/j.ejmech.2019.111604","article-title":"Synthesis of polyfluoroalkyl sp2-iminosugar glycolipids and evaluation of their immunomodulatory properties towards anti-tumor, anti-leishmanial and anti-inflammatory therapies","volume":"182","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib133","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.02.078","article-title":"sp2-Iminosugar glycolipids as inhibitors of lipopolysaccharide-mediated human dendritic cell activation in\u00a0vitro and of acute inflammation in mice in\u00a0vivo","volume":"169","author":"Schaeffer","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112438_bib134","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.fct.2017.11.050","article-title":"The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N, 6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv. 2 microglial cells and retinal explants","volume":"111","author":"Alcalde-Est\u00e9vez","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejmech.2020.112438_bib135","series-title":"C34. ILD and IPF: Clinical and Mechnistic Studies","article-title":"Visualizing CCR2-mediated inflammation in pulmonary fibrosis","author":"Atkinson","year":"2019"},{"key":"10.1016\/j.ejmech.2020.112438_bib136","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/jgs.14965","article-title":"EN abling reduction of low-grade inflammation in SE niors pilot study: concept, rationale, and design","volume":"65","author":"Manini","year":"2017","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.ejmech.2020.112438_bib137","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/gerona\/gly204","article-title":"The enabling reduction of low-grade inflammation in seniors (ENRGISE) pilot study: screening methods and recruitment results","volume":"74","author":"Cauley","year":"2019","journal-title":"J.\u00a0Gerontol.: Series A"},{"key":"10.1016\/j.ejmech.2020.112438_bib138","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/OPTH.S6541","article-title":"Difluprednate for the prevention of ocular inflammation postsurgery: an update","volume":"5","author":"Donnenfeld","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejmech.2020.112438_bib139","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/09273948.2017.1407433","article-title":"Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: pooled efficacy analysis of two phase 3 studies","volume":"27","author":"Sheppard","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejmech.2020.112438_bib140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/OPTH.S185800","article-title":"Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery","volume":"13","author":"Kim","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejmech.2020.112438_bib141","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jcrs.2018.07.015","article-title":"Safety of IBI-10090 for inflammation associated with cataract surgery: phase 3 multicenter study","volume":"44","author":"Donnenfeld","year":"2018","journal-title":"J.\u00a0Cataract Refract. Surg."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420304098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:13:03Z","timestamp":1759327983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420304098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":141,"alternative-id":["S0223523420304098"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112438","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in the development of heterocyclic anti-inflammatory agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112438"}}